BACKGROUND: Genital ulcer disease (GUD), including syphilis, is an important cause of morbidity in low and middle income (LMI) countries and syphilis transmission is associated with HIV transmission. METHODS: We conducted a literature review to evaluate syphilis infection among drug users in LMI countries for the period 1995-2007. Countries were categorized using the World Bank Atlas method [The World Bank. (2007). Data and statistics: Country groups. Retrieved online October 18, 2007 at http://go.worldbank.org/D7SN0B8YU0] according to 2006 gross national income per capita. RESULTS: Thirty-two studies were included (N=13,848 subjects), mostly from Southeast Asia with some from Latin America, Eastern Europe, Central and East Asia, North Africa and the Middle East but none from regions such as Sub-Saharan Africa. The median prevalence of overall lifetime syphilis (N=32 studies) was 11.1% (interquartile range: 6.3-15.3%) and of HIV (N=31 studies) was 1.1% (interquartile range: 0.22-5.50%). There was a modest relation (r=0.27) between HIV and syphilis prevalence. Median syphilis prevalence by gender was 4.0% (interquartile range: 3.4-6.6%) among males (N=11 studies) and 19.9% (interquartile range: 11.4-36.0%) among females (N=6 studies). There was a strong relation (r=0.68) between syphilis prevalence and female gender that may be related to female sex work. CONCLUSION: Drug users in LMI countries have a high prevalence of syphilis but data are limited and, in some regions, entirely lacking. Further data are needed, including studies targeting the risks of women. Interventions to promote safer sex, testing, counselling and education, as well as health care worker awareness, should be integrated in harm reduction programs and health care settings to prevent new syphilis infections and reduce HIV transmission among drug users and their partners in LMI countries.
BACKGROUND:Genital ulcer disease (GUD), including syphilis, is an important cause of morbidity in low and middle income (LMI) countries and syphilis transmission is associated with HIV transmission. METHODS: We conducted a literature review to evaluate syphilis infection among drug users in LMI countries for the period 1995-2007. Countries were categorized using the World Bank Atlas method [The World Bank. (2007). Data and statistics: Country groups. Retrieved online October 18, 2007 at http://go.worldbank.org/D7SN0B8YU0] according to 2006 gross national income per capita. RESULTS: Thirty-two studies were included (N=13,848 subjects), mostly from Southeast Asia with some from Latin America, Eastern Europe, Central and East Asia, North Africa and the Middle East but none from regions such as Sub-Saharan Africa. The median prevalence of overall lifetime syphilis (N=32 studies) was 11.1% (interquartile range: 6.3-15.3%) and of HIV (N=31 studies) was 1.1% (interquartile range: 0.22-5.50%). There was a modest relation (r=0.27) between HIV and syphilis prevalence. Median syphilis prevalence by gender was 4.0% (interquartile range: 3.4-6.6%) among males (N=11 studies) and 19.9% (interquartile range: 11.4-36.0%) among females (N=6 studies). There was a strong relation (r=0.68) between syphilis prevalence and female gender that may be related to female sex work. CONCLUSION: Drug users in LMI countries have a high prevalence of syphilis but data are limited and, in some regions, entirely lacking. Further data are needed, including studies targeting the risks of women. Interventions to promote safer sex, testing, counselling and education, as well as health care worker awareness, should be integrated in harm reduction programs and health care settings to prevent new syphilis infections and reduce HIV transmission among drug users and their partners in LMI countries.
Authors: T Azim; M N Islam; J Bogaerts; M A Mian; M S Sarker; K R Fattah; P Simmonds; C Jenkins; M R Choudhury; V I Mathan Journal: AIDS Date: 2000-01-28 Impact factor: 4.177
Authors: S Baqi; N Nabi; S N Hasan; A J Khan; O Pasha; N Kayani; R A Haque; M Khurshid; S Fisher-Hoch; S P Luby; J B McCormick Journal: J Acquir Immune Defic Syndr Hum Retrovirol Date: 1998-05-01
Authors: Don C Des Jarlais; Kamyar Arasteh; Theresa Perlis; Holly Hagan; Abu Abdul-Quader; Douglas D Heckathorn; Courtney McKnight; Heidi Bramson; Chris Nemeth; Lucia V Torian; Samuel R Friedman Journal: AIDS Date: 2007-01-11 Impact factor: 4.177
Authors: H B de Carvalho; F Mesquita; E Massad; R C Bueno; G T Lopes; M A Ruiz; M N Burattini Journal: J Acquir Immune Defic Syndr Hum Retrovirol Date: 1996-05-01
Authors: C Beyrer; M H Razak; J Jittiwutikarn; V Suriyanon; T Vongchak; N Srirak; S Kawichai; S Tovanabutra; K Rungruengthanakit; P Sawanpanyalert; T Sripaipan; D D Celentano Journal: Int J STD AIDS Date: 2004-10 Impact factor: 1.359
Authors: Catherine S Todd; Abdul Nasir; Mohammad Raza Stanekzai; Abdullah M S Abed; Steffanie A Strathdee; Christian T Bautista; Paul T Scott; Boulos A Botros; Jeffrey Tjaden Journal: Sex Transm Dis Date: 2010-11 Impact factor: 2.830
Authors: Heather A Pines; Melanie L Rusch; Alicia Vera; Gudelia Rangel; Carlos Magis-Rodriguez; Steffanie A Strathdee Journal: Int J STD AIDS Date: 2015-01-22 Impact factor: 1.359
Authors: Sylvester Yao Lokpo; Ellis Owusu-Dabo; John Gameli Deku; Verner Ndudiri Orish; Gideon Kye-Duodu; Francis Abeku Ussher; Thomas Boakye; Daniel Adigbli; Louis Selassie Ameke; William Klutse Fianko; Robert Adedze-Kpodo; Henry Komla Letsa; Worlanyo Tashie; Noble Selorm Gbormittah; Godsway Edem Kpene; James Osei-Yeboah Journal: Biomed Res Int Date: 2021-11-09 Impact factor: 3.411